Veldoreotide (DG3173) TFA a somatostatin analogue, binds to and activate the somatostatin receptors (SSTR) 2, 4, and 5. Veldoreotide TFA inhibits growth hormone (GH) secretion in adenomas compared with Octreotide (HY-P0036). Veldoreotide has the potential to be used as pain modulating agent[1]

Veldoreotide (DG3173) TFA a somatostatin analogue, binds to and activate the somatostatin receptors (SSTR) 2, 4, and 5. Veldoreotide TFA inhibits growth hormone (GH) secretion in adenomas compared with Octreotide (HY-P0036). Veldoreotide has the potential to be used as pain modulating agent[1]

VENTX Human Pre-designed siRNA Set A contains three designed siRNAs for VENTX gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

VEPH1 Human Pre-designed siRNA Set A contains three designed siRNAs for VEPH1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Verapamil (hydrochloride) (Standard) is the analytical standard of Verapamil (hydrochloride). This product is intended for research and analytical applications. Verapamil hydrochloride ((±)-Verapamil hydrochloride) is a calcium channel blocker and a potent and orally active first-generation P-glycoprotein (P-gp) inhibitor. Verapamil hydrochloride also inhibits CYP3A4. Verapamil hydrochloride has the potential for high blood pressure, heart arrhythmias and […]

Verapamil (hydrochloride) (Standard) is the analytical standard of Verapamil (hydrochloride). This product is intended for research and analytical applications. Verapamil hydrochloride ((±)-Verapamil hydrochloride) is a calcium channel blocker and a potent and orally active first-generation P-glycoprotein (P-gp) inhibitor. Verapamil hydrochloride also inhibits CYP3A4. Verapamil hydrochloride has the potential for high blood pressure, heart arrhythmias and […]

Verapamil (hydrochloride) (Standard) is the analytical standard of Verapamil (hydrochloride). This product is intended for research and analytical applications. Verapamil hydrochloride ((±)-Verapamil hydrochloride) is a calcium channel blocker and a potent and orally active first-generation P-glycoprotein (P-gp) inhibitor. Verapamil hydrochloride also inhibits CYP3A4. Verapamil hydrochloride has the potential for high blood pressure, heart arrhythmias and […]

Verapamil (hydrochloride) (Standard) is the analytical standard of Verapamil (hydrochloride). This product is intended for research and analytical applications. Verapamil hydrochloride ((±)-Verapamil hydrochloride) is a calcium channel blocker and a potent and orally active first-generation P-glycoprotein (P-gp) inhibitor. Verapamil hydrochloride also inhibits CYP3A4. Verapamil hydrochloride has the potential for high blood pressure, heart arrhythmias and […]

Verapamil-d7 is the deuterium labeled Verapamil (HY-14275). Verapamil ((±)-Verapamil) is a calcium channel blocker and a potent and orally active first-generation P-glycoprotein (P-gp) inhibitor. Verapamil also inhibits CYP3A4. Verapamil has the potential for high blood pressure, heart arrhythmias and angina research[1][2][3].

Versipelostatin is a GRP78/Bip molecular chaperone down-regulator and can be isolated from the culture broth of Streptomyces versipellis 4083-SVS6[1].

Verteporfin (Standard) is the analytical standard of Verteporfin. This product is intended for research and analytical applications. Verteporfin (CL 318952) is a photosensitizer for photodynamic therapy to eliminate the abnormal blood vessels in the eye associated with conditions such as age-related macular degeneration. Verteporfin is a YAP inhibitor which disrupts YAP-TEAD interactions. Verteporfin induces cell […]

VEZF1 Human Pre-designed siRNA Set A contains three designed siRNAs for VEZF1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

VEZT Human Pre-designed siRNA Set A contains three designed siRNAs for VEZT gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

VGF Human Pre-designed siRNA Set A contains three designed siRNAs for VGF gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

VGLL1 Human Pre-designed siRNA Set A contains three designed siRNAs for VGLL1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

VGLL2 Human Pre-designed siRNA Set A contains three designed siRNAs for VGLL2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

VGLL3 Human Pre-designed siRNA Set A contains three designed siRNAs for VGLL3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

VGLL4 Human Pre-designed siRNA Set A contains three designed siRNAs for VGLL4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

VH 032 amide-PEG6-amine hydrochloride (Step 4) is a functionalized von-Hippel-Lindau protein-ligand (VHL) for PROTAC development, consisting of an E3 ligand and a PEG6 ligand. Terminal amines can be coupled to target protein ligands[1].

VHL Human Pre-designed siRNA Set A contains three designed siRNAs for VHL gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

VHL Ligand 14 (Compound 11) is a VHL ligand for design of PROTAC estrogen receptor α (ERα) degraders, with a binding affinity IC50 of 196 nM[1].

VHL Ligand 14 (Compound 11) is a VHL ligand for design of PROTAC estrogen receptor α (ERα) degraders, with a binding affinity IC50 of 196 nM[1].

VHL Ligand 14 (Compound 11) is a VHL ligand for design of PROTAC estrogen receptor α (ERα) degraders, with a binding affinity IC50 of 196 nM[1].

VHL Ligand 14 (Compound 11) is a VHL ligand for design of PROTAC estrogen receptor α (ERα) degraders, with a binding affinity IC50 of 196 nM[1].

VHL Ligand 14 (Compound 11) is a VHL ligand for design of PROTAC estrogen receptor α (ERα) degraders, with a binding affinity IC50 of 196 nM[1].

VHL-SF2 is a VHL ligand, and can be used for synthesis of PROTACs[1]

VHLL Human Pre-designed siRNA Set A contains three designed siRNAs for VHLL gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

VI-60 is a dual, orally active inhibitor of cPLA2 and COX-2, which reveals an anti-inflammtory efficacy through the inhibition of p38 MAPK/cPLA2/COX-2/PGE2 pathway[1].

Vibsanin C is a subtype of vibsanin-type diterpenoids with cytotoxic and antibacterial activities[1].

Vibunazole is a new antifungal azole.

Victoria Blue R (Basic Blue 11) is a multifunctional dye. Dyes are important tools in biological experiments. They can help researchers observe and analyze cell structures, track biomolecules, evaluate cell functions, distinguish cell types, detect biomolecules, study tissue pathology and monitor microorganisms. Their applications range from basic scientific research to clinical A wide range of […]

VIL1 Human Pre-designed siRNA Set A contains three designed siRNAs for VIL1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Vilaprisan is a selective progesterone receptor modulator (SPRM), which targets progesterone receptors. Vilaprisan can inhibit cell proliferation and stimulate apoptosis. Vilaprisan has oral efficacy and anti-proliferative activity against uterine leiomyoma (UF[1]).

Vilazodone-d8 hydrochloride is deuterated labeled Vilazodone (HY-14262). Vilazodone (EMD 68843; SB 659746A) is a potent, selective and orally active?serotonin?reuptake inhibitor (SSRI) and partial?5-HT1A receptor agonist. Vilazodone exhibits antidepressant efficacy in vivo can be used for the research of major depressive disorder (MDD) and affective disorders[1][2].

VILL Human Pre-designed siRNA Set A contains three designed siRNAs for VILL gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Viltolarsen (NS-065/NCNP-01) sodium is a phosphorodiamidate morpholino antisense oligonucleotide. Viltolarsen sodium binds to exon 53 of the dystrophin mRNA precursor and restores the amino acid open-reading frame by skipping exon 53, resulting in the production of a shortened dystrophin protein that contains essential functional portions. Viltolarsen sodium has the potential for Duchenne muscular dystrophy (DMD) […]

Viltolarsen (NS-065/NCNP-01) sodium is a phosphorodiamidate morpholino antisense oligonucleotide. Viltolarsen sodium binds to exon 53 of the dystrophin mRNA precursor and restores the amino acid open-reading frame by skipping exon 53, resulting in the production of a shortened dystrophin protein that contains essential functional portions. Viltolarsen sodium has the potential for Duchenne muscular dystrophy (DMD) […]

Viltolarsen (NS-065/NCNP-01) sodium is a phosphorodiamidate morpholino antisense oligonucleotide. Viltolarsen sodium binds to exon 53 of the dystrophin mRNA precursor and restores the amino acid open-reading frame by skipping exon 53, resulting in the production of a shortened dystrophin protein that contains essential functional portions. Viltolarsen sodium has the potential for Duchenne muscular dystrophy (DMD) […]

VIM Human Pre-designed siRNA Set A contains three designed siRNAs for VIM gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

VIP Human Pre-designed siRNA Set A contains three designed siRNAs for VIP gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

VIPAS39 Human Pre-designed siRNA Set A contains three designed siRNAs for VIPAS39 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

VIPR1 Human Pre-designed siRNA Set A contains three designed siRNAs for VIPR1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

VIPR2 Human Pre-designed siRNA Set A contains three designed siRNAs for VIPR2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Virgilagicin is a Gram-positive active antibiotic that has a dual polyprenyl phosphate binding mechanism that impedes resistance development[1].

VIRMA Human Pre-designed siRNA Set A contains three designed siRNAs for VIRMA gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Virodhamine (hydrochloride) is a cannabinoid CB1 receptor partial agonist and cannabinoid CB2 receptor full agonist[1].

VISTA-IN-3 (Compound A4) is a potent VISTA small molecule inhibitor with a KD value of 0.49 μM. VISTA-IN-3 can induce the release of IFN-γ cytokines. VISTA-IN-3 synergistically enhances anti-cancer activity with PD-L1 antibody[1].